Trisalus Life Sciences (NASDAQ: TLSI) reported Q3 2023 earnings per share (EPS) of -$0.13, up 99.5% year over year. Total Trisalus Life Sciences earnings for the quarter were -$1.29 million. In the same quarter last year, Trisalus Life Sciences's earnings per share (EPS) was -$25.95.
As of Q4 2023, Trisalus Life Sciences's earnings has grown year over year. Trisalus Life Sciences's earnings in the past year totalled -$76.60 million.
What was TLSI's revenue last quarter?
Trisalus Life Sciences (NASDAQ: TLSI) reported Q3 2023 revenue of $5.19 million up 32.37% year over year. In the same quarter last year, Trisalus Life Sciences's revenue was $3.92 million.
What was TLSI's revenue growth in the past year?
As of Q4 2023, Trisalus Life Sciences's revenue has grown 43.34% year over year. This is 36.61 percentage points higher than the US Medical Devices industry revenue growth rate of 6.73%. Trisalus Life Sciences's revenue in the past year totalled $25.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.